Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
2,718,819
-
Shares change
-
+302,974
-
Total reported value, excl. options
-
$141,599,579
-
Value change
-
+$16,256,174
-
Number of buys
-
22
-
Number of sells
-
31
-
Price
-
$52.06
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q4 2020
As of 31 Dec 2020 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,718,819 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, JPMORGAN CHASE & CO, FACTORY MUTUAL INSURANCE CO, BANK OF AMERICA CORP /DE/, Wharton Business Group, LLC, LPL Financial LLC, Hochman Cole Investment Advisors, Inc., HighTower Advisors, LLC, and FIRST CITIZENS BANK & TRUST CO.
This table shows 79 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.